Responsible E-Prescribing Needs E-Discontinuation

Published in: JAMA, Volume 317, Number 5 (February 7, 2017), Pages 469-470. doi:10.1001/jama.2016.19908

Posted on on March 12, 2019

by Shira H. Fischer, Adam J. Rose

Read More

Access further information on this document at JAMA

This article was published outside of RAND. The full text of the article can be found at the link above.

Implementation of electronic prescribing, also known as e-prescribing, has been one of the successes of health information technology and an advance in health care delivery. Clinician uptake of e-prescribing has been substantial, in part because it is now required by health plans, insurers, and hospitals. As of April 2014, 70% of physicians were e-prescribing, an increase from 7% who used e-prescribing in December 2008. e-Prescribing reduces the number of illegible prescriptions and helps to address and may reduce medical errors through integrated tools that provide information on allergies, drug-drug interactions, and appropriate dosing. One primary care study involving 30 clinicians (of whom 15 adopted e-prescribing) and more than 3500 prescriptions at baseline and 1 year later showed that prescribing errors decreased among the e-prescribers from 42.5 per 100 prescriptions at baseline to 6.6 per 100 prescriptions in a single year with the adoption of e-prescribing. However, e-prescribing also has been associated with some challenges; for example, when a pharmacy is closed or does not have the requested medication and it is impossible to contact the prescribing physician; there are also issues with the many clicks it takes to order a prescription and the numerous false-positive alerts that lead to alert fatigue.

Research conducted by

This report is part of the RAND Corporation External publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

Our mission to help improve policy and decisionmaking through research and analysis is enabled through our core values of quality and objectivity and our unwavering commitment to the highest level of integrity and ethical behavior. To help ensure our research and analysis are rigorous, objective, and nonpartisan, we subject our research publications to a robust and exacting quality-assurance process; avoid both the appearance and reality of financial and other conflicts of interest through staff training, project screening, and a policy of mandatory disclosure; and pursue transparency in our research engagements through our commitment to the open publication of our research findings and recommendations, disclosure of the source of funding of published research, and policies to ensure intellectual independence. For more information, visit

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.